Navidea Biopharmaceuticals Pattern Recognition Tristar Pattern

NAVBDelisted Stock

USD 0.0001 0.00 0.00%

The pattern recognition view organizes Tristar Pattern recognition and supporting indicators around Navidea Biopharmaceutica. It emphasizes pattern recognition signals tied to momentum and continuation while keeping volatility, risk, and performance context in view.

Symbol

Recognition

We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.

Navidea Biopharmaceutica Technical Analysis Modules

Most technical analysis of Navidea Biopharmaceutica help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Navidea from various momentum indicators to cycle indicators. When you analyze Navidea charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

	Cycle Indicators
	Math Operators
	Math Transform
	Momentum Indicators
	Overlap Studies
	Pattern Recognition
	Price Transform
	Statistic Functions
	Volatility Indicators
	Volume Indicators

Pink Sheet Overview, Methodology & Data Sources

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. Navidea Biopharmaceuticals, Inc. was incorporated in 1983 and is headquartered in Dublin, Ohio. Navidea Biopharmaceutica operates under Biotechnology classification in the United States and is traded on AMEX Exchange. It employs 11 people. This overview emphasizes how Navidea Biopharmaceutica compares to peers on valuation quality and operating consistency. Current metrics include P/E of 0.53, P/B of 8.16. Navidea Biopharmaceutica has a market cap of 8.04 M, P/E of 0.53, ROE of -11.0%.

Methodology

Unless otherwise specified, financial data for Navidea Biopharmaceuticals is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Navidea (USA Stocks:NAVB) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Information presented is compiled from public filings and market reference sources and official institutions such as U.S. Securities and Exchange Commission (SEC) via EDGAR. Updates can be delayed depending on reporting conventions. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Navidea Biopharmaceuticals may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.

This content is curated and reviewed by:

Ellen Johnson - Member of Macroaxis Editorial Board

Last reviewed on February 25th, 2026

Be your own money manager

Tracking Navidea Biopharmaceutica inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. The stronger process keeps portfolio transparency high without forcing constant manual review of every holding.

Generate Optimal Portfolios

Align your risk and return expectations

Risk tolerance and time horizon inputs allow Macroaxis optimization to estimate acceptable risk levels. The output provides a structured risk context for return targets.

Fix portfolios for free

Navidea Biopharmaceutica has a market cap of 8.04 M, ROE of -11.0%. Use Correlation Analysis to explore allocation context. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

Navidea Biopharmaceutica at P/E 0.53 and ROE -11.0% (8.04 Million market cap) - this analysis works best as a complementary layer when evaluating how the position fits in a broader portfolio. Those metrics give investors a concrete basis for the diversification and risk analysis available below. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Consideration for investing in Navidea Pink Sheet

Navidea Biopharmaceutica risk assessment requires review of trading venue structure.

	Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges
	Portfolio Anywhere Track or share privately all of your investments from the convenience of any device
	Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments
	Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
	CEOs Directory Screen CEOs from public companies around the world
	Share Portfolio Track or share privately all of your investments from the convenience of any device
	Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC